GlassScriptPhysician profile
Jacobo Abraham Cabrera-Ramirez
NPI 1942792981
$12,084.18
in general payments reported to CMS, 2019-2025
14 companies · $5,087 in 2025
The $5,087 reported for 2025 was more than what 92% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $269 · 2024: $6,728 · 2025: $5,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,681 · Food and Beverage: $5,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,681.37 |
| Food and Beverage | $5,402.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $3,142.02 | 2024-2025 | Evoke |
| Abbott Laboratories | $2,435.07 | 2024-2025 | Proclaim, Octrode, Prodigy |
| Boston Scientific Corporation | $1,485.55 | 2024-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Intracept |
| Nalu Medical, INC. | $1,272.01 | 2024-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $1,114.41 | 2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Navlock |
| Mml US, INC. | $761.97 | 2024 | Reactiv8 |
| Biotronik Nro, INC. | $659.77 | 2024-2025 | Prospera |
| Nevro Corp. | $630.89 | 2024 | Senza |
| Spr Therapeutics, INC | $288.26 | 2023-2025 | Sprint Pns System |
| Avanos Medical | $128.79 | 2023 | Generator |
| Averitas Pharma INC. | $75.38 | 2024 | Qutenza |
| Globus Medical, INC. | $68.17 | 2025 | Omnia |
| Pacira Pharmaceuticals Incorporated | $16.17 | 2023 | Exparel |
| Foundation Fusion Solutions, LLC | $5.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacobo Cabrera-Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.